EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

Active Implantable Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007

This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.

Last updated 19 April 2024. Database contains 4753 unique substances/entries.

Filter the list

Showing 101 - 150 of 4,753 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex BLUE TZ 4312	423-770-3	-	Eye Dam. 1
trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate SCARLET 12 04 262	406-820-9	159317-41-6	Eye Irrit. 2
trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) SÄUREBLAU 82 226	402-500-8	104105-46-6	Eye Dam. 1
trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) BROWN 1612969	407-110-1	480445-87-2	Eye Dam. 1; Skin Sens. 1
tris[2-chloro-1-(chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2
tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate LEXMARK YELLOW DYE 415; PRISM YELLOW	406-073-9	131013-81-5	Acute Tox. 3
tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) PIGMENTBLAU 1755	403-210-4	108300-90-9	Eye Dam. 1
tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1	yes
Tris(4-nonylphenyl, branched) phosphite show/hide Phenol, p-sec-nonyl-, phosphite EC / List no: - \| CAS no: 106599-06-8 Tris(nonylphenyl) phosphite EC / List no: 247-759-6 \| CAS no: 26523-78-4 tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 \| CAS no: - Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 \| CAS no: 3050-88-2 Phenol, p-isononyl-, phosphite (3:1) EC / List no: - \| CAS no: 31631-13-7	799-976-5	-		yes
tris(2-methoxyethoxy)vinylsilane; 6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecane	213-934-0	1067-53-4	Repr. 1B
tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2; Repr. 1B; Acute Tox. 4	yes
tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate ACETOACETYLORTHOSINIC ACID, A6-SALT	403-760-5	68030-79-5	Skin Sens. 1
tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate	-	7276-58-6	Acute Tox. 4
tripropyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
tripropylammonium dihydrogenphosphate TRYPROPYLAMMONIUM DIHYDROGENPHOSPHAT	433-700-3	35687-90-2	Acute Tox. 4
triphenyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)	442-960-7	332350-93-3	Acute Tox. 3; Eye Dam. 1
triphenyl phosphite	202-908-4	101-02-0	Eye Irrit. 2; Skin Irrit. 2
trioctyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
trioctylstannane TZ 02508	413-320-4	869-59-0	STOT RE 1; Skin Irrit. 2
trinickel tetrasulfide	-	12137-12-1	Carc. 1A; STOT RE 1; Skin Sens. 1
trinickel disulfide; nickel subsulfide	234-829-6	12035-72-2	Carc. 1A; Muta. 2; STOT RE 1; Skin Sens. 1
trinickel boride	234-495-1	12007-02-2	Carc. 1A; STOT RE 1; Skin Sens. 1
trinickel bis(orthophosphate)	233-844-5	10381-36-9	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
trinickel bis(arsenite)	-	74646-29-0	Carc. 1A; STOT RE 1; Skin Sens. 1
trinickel bis(arsenate); nickel(II) arsenate	236-771-7	13477-70-8	Carc. 1A; STOT RE 1; Skin Sens. 1
trimethyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 2; Acute Tox. 1
trimethylopropane tri(3-aziridinylpropanoate); (TAZ)	257-765-0	52234-82-9	Muta. 2; Eye Dam. 1; Skin Sens. 1
trimethylenediaminetetraacetic acid 1,3-PDTA; AGENT CHELATANT KODAK NO.1; DISSOLVINE PDZ; HAMPSHIRE PDTA; KODAK CHELATING AGENT NO.1; TRILON R FS	400-400-9	1939-36-2	Acute Tox. 4; Eye Dam. 1
trimethyl borate	204-468-9	121-43-7	Flam. Liq. 3; Acute Tox. 4
trimethoxyvinylsilane; trimethoxy(vinyl)silane	220-449-8	2768-02-7	Skin Sens. 1B
trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate IJA-286; IJBK-286; IJBK-286-LI	403-650-7	117409-78-6	Expl. 1.3
trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) ACID BLUE FC 77890	414-290-5	149564-65-8	Acute Tox. 4
Trilead dioxide phosphonate	235-252-2	12141-20-7		yes
Trilead diarsenate	222-979-5	3687-31-8		yes
trilead bis(orthophosphate)	231-205-5	7446-27-7	Repr. 1A; STOT RE 2
Trilead bis(carbonate)dihydroxide	215-290-6	1319-46-6		yes
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-)	235-688-3	12519-85-6	Carc. 1A; STOT RE 1; Skin Sens. 1
triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6- (2,2,2-trifluoroethoxy)-1,3,5- triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate	603-146-9	126535-15-7	Carc. 2
trifluralin (ISO) (containing <0.5 ppm NPDA); α, α, α-trifluoro-2,6-dinitro-N, N-dipropyl-p-toluidine (containing; < 0,5 ppm NPDA); 2,6-dinitro-N, N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N, N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)	216-428-8	1582-09-8	Carc. 2; Skin Sens. 1
trifluoroiodomethane; trifluoromethyl iodide	219-014-5	2314-97-8	Muta. 2
trifluoroacetic acid . . . %	200-929-3	76-05-1	Acute Tox. 4; Skin Corr. 1A
triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine	614-708-8	68694-11-1	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
trifloxystrobin (ISO); (E, E)-α-methoxyimino-2-[[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester	604-237-6	141517-21-7	Skin Sens. 1
trifenmorph (ISO);4-tritylmorpholine	215-812-2	1420-06-0	Acute Tox. 4
triethyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 2; Acute Tox. 1
triethylamine	204-469-4	121-44-8	Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
triethyl phosphate	201-114-5	78-40-0	Acute Tox. 4
triethyl arsenate TRIETHYLARSENAT; TRIETHYLARSENATE; TRIETHYLARSENATE (TEASAT)	427-700-2	15606-95-8	Carc. 1A; Acute Tox. 3	yes
triethoxyisobutylsilane DYNASILAN BH N; DYNASILAN BSM 100 N; DYNASILAN NH 42	402-810-3	17980-47-1	Skin Irrit. 2

Showing 101 - 150 of 4,753 results.

Export search results to:

EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

Active Implantable Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 19 April 2024. Database contains 4753 unique substances/entries.

Footer Nav Items